Status:
COMPLETED
Ventilation With Supraglottic Airway Devices
Lead Sponsor:
Reham Ali Abdelhaleem Abdelrahman
Conditions:
Laryngeal Masks Comparison
Eligibility:
FEMALE
18-55 years
Brief Summary
Airo-Q Self Pressurized airway device with Blocker will be compared with Proseal LMA in anesthetized adult female patients undergoing elective surgeries to discuss the influence of different head and ...
Eligibility Criteria
Inclusion
- Adult female patients ASA I\&II.
- age: 18-55 years old.
- BMI\< 35.
- undergoing elective surgeries.
Exclusion
- Patients with history of upper respiratory tract infections and obstructive sleep apnea.
- Patients who are potentially full stomach such as trauma, pregnancy, history of gastric regurgitation \&heart burn, those with esophageal reflux or hiatus hernia.
- Patients with coagulation disorders.
- Patients with El-Ganzouri airway score ≥ 5 will.
Key Trial Info
Start Date :
June 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04421261
Start Date
June 4 2020
End Date
December 1 2021
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of anesthesia, Surgical ICU and Pain Management
Cairo, Egypt, 11562